CagriSemaが2型糖尿病と過剰体重の患者の減量にどれほど効果的かを調べる研究

基本情報

NCT ID

NCT05394519

ステータス

完了

試験のフェーズ

第3相

試験タイプ

介入

目標被験者数

1,200

治験依頼者名

Novo Nordisk A/S

概要

This study will look at how well the new medicine CagriSema helps people living with excess body weight and type 2 diabetes losing weight. Participants will either get CagriSema or a dummy medicine. Which treatment they get is decided by chance. The study will last for about 1½ years. Women cannot take part if pregnant, breast-feeding or planning to get pregnant during the study period.

対象疾患

介入

依頼者（Sponsor）

実施施設 (5)